Please ensure Javascript is enabled for purposes of website accessibility

WellPoint Hits the Trifecta

By Brian Orelli, PhD – Updated Apr 6, 2017 at 3:05AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A triple combination of bad news sinks the insurer's earnings.

WellPoint (NYSE:WLP) hit the trifecta yesterday, but it wasn't the one that makes you leave the track happy. This triple combination -- investment losses, lower enrollment, and higher medical costs -- caused earnings per share to sink 57%.

Fortunately, investors saw it coming. The stock actually ended up 4% on the day.

The $350.5 million after-tax investment loss hurt, but the damage is done, and the company is still above its required level of capitalization. Aetna (NYSE:AET) and Humana (NYSE:HUM) also reported impairments last year, but none of them are close to needing a bailout like AIG (NYSE:AIG).

WellPoint's membership dropped 1% in the quarter as people lost jobs and couldn't pay for COBRA. Completing the trifecta, medical care ratio -- medical costs divided by premiums -- was up to 83.4% from 82.9% a year earlier. Those higher costs are cutting directly into the bottom line.

Fortunately, premiums reset eventually, and the company should be able to get the cost issue under control this year. Investors will have to wait until the end of next month at the company's investor day to get the full details, but management did say they expect to see earnings in the "low single digits." Not great, but at least it's headed in the right direction.

WellPoint and the rest of the health insurance industry -- UnitedHealth Group (NYSE:UNH), Cigna (NYSE:CI), and the like -- will have two opposing forces working on their stocks this year. On one hand, they should be at the front edge of the recovery -- increased employment means increased revenue -- but the unknowns that surround Washington's plans for universal health care (or some derivation thereof) will continue to drag on their stocks.

The only thing WellPoint can do is hope that the economy recovers, hope Washington doesn't dilly-daddle, and keep costs under control while it rides this out.

More Foolishness:

WellPoint and UnitedHealth are Motley Fool Inside Value recommendations. If you're interested in picking through the wreckage for possible turnaround candidates, you should have the Inside Value team on your side. Check it out for free with a 30-day trial.

Fool contributor Brian Orelli, Ph.D., hit a trifecta at his only trip to the Kentucky Derby. He doesn't own shares of any company mentioned in this article. The Fool owns shares of UnitedHealth, which is a Motley Fool Stock Advisor selection. The Fool's disclosure policy is free insurance from us.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Elevance Health Inc. Stock Quote
Elevance Health Inc.
ELV
$448.14 (-1.26%) $-5.71
Aetna Inc. Stock Quote
Aetna Inc.
AET
American International Group, Inc. Stock Quote
American International Group, Inc.
AIG
$48.41 (-2.73%) $-1.36
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$508.36 (-1.02%) $-5.25
Humana Inc. Stock Quote
Humana Inc.
HUM
$482.63 (-0.88%) $-4.27
Cigna Corporation Stock Quote
Cigna Corporation
CI

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.